▁There 10.375
▁is 3.4296875
▁currently 7.9296875
▁a 2.640625
▁severe 6.1484375
▁lack 4.87109375
▁of 1.1474609375
▁information 6.16015625
▁about 4.15234375
▁the 2.23046875
▁effects 7.9140625
▁of 0.861328125
▁op 11.5625
i 3.64453125
ates 2.02734375
. 2.845703125
▁They 5.24609375
▁manage 8.7109375
▁pain 9.078125
▁successfully 6.7890625
, 1.8818359375
▁but 1.67578125
▁the 2.853515625
▁past 8.46875
▁few 3.15625
▁dec 2.833984375
ades 0.0005788803100585938
▁indicated 8.828125
▁the 2.703125
▁growing 4.87109375
▁concern 4.859375
▁regarding 3.826171875
▁op 2.91015625
iate 0.402587890625
▁ab 2.14453125
use 0.0264434814453125
▁in 2.83984375
▁forms 10.21875
▁of 0.425537109375
▁over 4.234375
d 0.42578125
ose 0.173095703125
▁and 1.1337890625
▁add 1.693359375
iction 0.0538330078125
. 0.30712890625
▁A 4.77734375
▁more 5.08984375
▁manage 7.328125
able 0.004581451416015625
▁and 2.41015625
▁sa 2.87109375
fer 0.00421905517578125
▁alternative 2.240234375
▁might 6.39453125
▁be 0.433837890625
▁medical 6.24609375
▁mar 0.5185546875
iju 0.0601806640625
ana 0.0018901824951171875
. 1.2197265625
▁However 4.5390625
, 0.0227203369140625
▁the 1.755859375
▁legal 3.478515625
▁status 1.7421875
▁and 2.830078125
▁novel 9.3984375
ty 0.5185546875
▁of 0.40673828125
▁this 2.087890625
▁drug 3.005859375
▁do 5.83203125
▁not 0.2286376953125
▁allow 1.564453125
▁finding 9.5625
▁a 1.623046875
▁large 5.69140625
▁number 1.837890625
▁of 0.0207672119140625
▁studies 1.9951171875
▁on 1.9228515625
▁its 1.4970703125
▁effect 2.80859375
iveness 0.216552734375
. 1.248046875
▁Specifically 7.75
, 0.1595458984375
▁it 2.859375
▁concerns 6.0546875
▁the 0.9052734375
▁emot 9.265625
ional 0.041412353515625
▁condition 5.87109375
▁of 0.841796875
▁patients 1.52734375
▁experien 6.26171875
cing 0.0007891654968261719
▁chron 3.509765625
ic 0.0017833709716796875
▁pain 0.378173828125
. 1.009765625
▁This 3.4375
▁research 3.90234375
▁paper 3.884765625
▁a 1.4140625
ims 0.00026702880859375
▁to 0.1854248046875
▁analyze 3.013671875
▁levels 10.828125
▁of 0.054168701171875
▁de 3.53515625
pression 0.04754638671875
▁and 0.92529296875
▁anx 0.88037109375
iety 0.00429534912109375
▁among 2.080078125
▁people 3.58203125
▁receiving 4.56640625
▁ther 5.59375
apy 0.060302734375
▁by 4.72265625
▁comparing 5.49609375
▁the 1.6865234375
▁effects 1.814453125
▁of 0.0726318359375
▁ph 6.9140625
arma 0.67333984375
ce 0.002109527587890625
ut 0.00023305416107177734
ical 0.0210723876953125
▁op 1.34765625
io 2.2578125
ids 0.424072265625
▁and 1.3720703125
▁MM 7.953125
. 6.5546875
<0x0A> 1.0703125
Chr 6.9609375
onic 0.02783203125
▁pain 0.3828125
▁is 0.88916015625
▁still 5.828125
▁considered 2.47265625
▁to 2.494140625
▁be 0.044097900390625
▁an 2.5625
▁extreme 5.859375
▁issue 3.970703125
▁among 3.001953125
▁at 9.34375
▁least 0.2041015625
▁ 0.435302734375
8 3.076171875
% 3.74609375
▁of 0.06658935546875
▁the 0.5439453125
▁residents 8.0
▁of 0.978515625
▁progress 14.125
ive 0.42333984375
▁countries 0.859375
. 0.63671875
▁The 2.08203125
▁introduction 7.328125
▁of 0.0567626953125
▁the 2.65625
▁study 6.67578125
▁describes 7.59765625
▁the 0.91845703125
▁apparent 8.4140625
▁link 4.35546875
▁between 0.1708984375
▁pain 3.169921875
▁and 0.423828125
▁dem 9.765625
oral 2.203125
ization 0.1717529296875
. 0.8955078125
▁Chron 4.90625
ic 0.0079193115234375
▁pain 0.1844482421875
▁is 1.484375
▁always 5.82421875
▁accompanied 1.3115234375
▁by 0.1112060546875
▁negative 3.634765625
▁emot 0.79736328125
ional 1.564453125
▁experiences 3.771484375
▁and 2.337890625
▁blocks 9.9609375
▁a 3.662109375
▁person 0.93310546875
’ 26.9375
s 2.787109375
▁ability 1.142578125
▁to 0.041351318359375
▁receive 6.10546875
▁joy 4.43359375
▁and 1.2177734375
▁satisfaction 2.908203125
▁from 1.4375
▁life 1.037109375
. 0.173828125
▁The 1.861328125
▁research 3.224609375
▁investig 4.703125
ates 0.2044677734375
▁the 0.52294921875
▁development 6.5625
▁of 0.148681640625
▁de 1.603515625
pression 0.1318359375
▁and 0.417724609375
▁anx 0.1441650390625
iety 0.0029201507568359375
▁among 1.3173828125
▁patients 1.0361328125
▁receiving 1.154296875
▁ph 3.041015625
arma 0.101806640625
ce 0.0014200210571289062
ut 0.000125885009765625
ical 0.005405426025390625
▁op 0.333740234375
io 0.61279296875
ids 0.10821533203125
▁and 1.1806640625
▁medical 1.9453125
▁mar 0.09375
iju 0.0059967041015625
ana 0.0010614395141601562
▁( 4.1328125
MM 0.11553955078125
) 1.560546875
▁as 2.994140625
▁severe 8.8828125
▁pain 4.7421875
kill 2.669921875
ers 0.000324249267578125
. 0.3076171875
▁It 2.5390625
▁comp 4.734375
ares 0.021087646484375
▁the 0.4501953125
▁effic 5.5
acy 0.003810882568359375
▁of 0.2198486328125
▁pres 5.0703125
cri 2.1328125
ptions 0.2052001953125
▁and 1.658203125
▁exam 6.58203125
ines 0.0212554931640625
▁the 0.5859375
▁possibility 4.09765625
▁of 0.11968994140625
▁post 8.578125
- 1.19140625
tre 1.935546875
at 0.0008511543273925781
ment 0.00569915771484375
▁de 3.02734375
pression 0.06591796875
. 2.25
<0x0A> 1.4189453125
The 1.25
▁study 2.2890625
▁was 3.37109375
▁conducted 0.8798828125
▁in 1.689453125
▁the 1.54296875
▁form 1.9814453125
▁of 0.007110595703125
▁collection 9.640625
▁and 1.626953125
▁analysis 0.75390625
▁of 0.038360595703125
▁statistical 4.4453125
▁data 0.1392822265625
. 1.0615234375
▁Part 5.3125
icip 0.202392578125
ants 0.06463623046875
▁were 0.92431640625
▁rec 3.64453125
ru 0.00182342529296875
ited 7.808208465576172e-05
▁for 3.998046875
▁six 7.5859375
▁months 0.5751953125
▁at 3.841796875
▁two 2.509765625
▁major 5.03125
▁pain 2.984375
▁relief 4.37890625
▁cent 1.3291015625
ers 0.03839111328125
▁in 0.8818359375
▁Israel 4.51953125
. 0.390625
▁The 1.1552734375
▁research 2.240234375
ers 1.9404296875
▁used 2.6484375
▁The 8.125
▁De 3.75
pression 0.00939178466796875
▁Module 9.6953125
▁of 1.041015625
▁the 0.32080078125
▁Pat 2.435546875
ient 0.0076446533203125
▁Health 0.095703125
▁Question 0.01407623291015625
naire 0.0193328857421875
▁and 3.046875
▁the 0.861328125
▁General 1.953125
ized 0.6513671875
▁An 0.023193359375
x 0.00019788742065429688
iety 0.0031414031982421875
▁Dis 1.3203125
order 0.058990478515625
▁Sc 1.1865234375
ale 0.07440185546875
▁to 1.8115234375
▁interview 6.69140625
▁participants 2.1875
, 3.94140625
▁evaluate 5.34375
▁their 0.7548828125
▁answers 6.63671875
, 0.74755859375
▁and 0.13671875
▁conduct 4.32421875
▁the 2.212890625
▁study 2.255859375
. 0.2315673828125
▁To 5.38671875
▁specifically 9.5703125
▁evaluate 2.71875
▁and 4.421875
▁compare 1.1787109375
▁the 0.35986328125
▁prob 11.203125
abilities 0.15380859375
▁of 0.134521484375
▁de 1.1015625
pression 0.045623779296875
▁or 4.37109375
▁anx 0.061737060546875
iety 0.0005650520324707031
▁among 2.025390625
▁the 1.9638671875
▁diverse 9.0234375
▁groups 1.69921875
, 1.3759765625
▁the 1.0546875
▁study 2.8359375
▁used 1.7470703125
▁multiple 4.7421875
▁log 2.982421875
istic 0.036956787109375
▁regression 0.0794677734375
▁analysis 0.73583984375
▁and 2.451171875
▁chose 9.03125
▁medical 6.8359375
▁mar 0.166015625
iju 0.0019779205322265625
ana 0.00043654441833496094
▁as 0.951171875
▁the 1.2177734375
▁control 3.4921875
▁group 1.1591796875
. 0.302001953125
<0x0A> 0.79345703125
This 3.3671875
▁type 5.44921875
▁of 0.010162353515625
▁study 1.837890625
▁is 1.7724609375
▁the 3.244140625
▁most 1.5234375
▁reve 9.09375
aling 0.0008883476257324219
▁and 1.0859375
▁inclus 6.546875
ive 0.0031719207763671875
, 2.658203125
▁as 1.8955078125
▁it 0.381591796875
▁contains 4.9921875
▁direct 6.71484375
▁responses 5.046875
▁from 0.8876953125
▁a 4.0859375
▁large 1.033203125
▁number 0.3603515625
▁of 0.003017425537109375
▁participants 1.3779296875
. 0.5703125
▁All 4.7265625
▁tools 9.265625
▁in 4.3125
▁the 0.6865234375
▁form 3.00390625
▁of 0.04412841796875
▁question 1.9189453125
na 0.056915283203125
ires 0.00020301342010498047
▁and 1.8466796875
▁scales 3.04296875
▁have 3.7578125
▁already 4.78125
▁been 0.2275390625
▁used 1.7626953125
▁and 2.3203125
▁proved 4.19921875
▁their 1.818359375
▁effic 3.427734375
acy 0.00012028217315673828
▁for 3.501953125
▁collect 4.95703125
ing 0.02557373046875
▁analyt 8.34375
ical 0.2471923828125
▁data 0.31494140625
. 0.45166015625
▁It 3.5859375
▁helps 4.58203125
▁to 0.95751953125
▁system 7.24609375
at 1.4375
ize 0.007595062255859375
▁and 1.5634765625
▁class 4.2109375
ify 0.002300262451171875
▁distinct 9.0234375
▁kinds 6.1015625
▁of 0.0250244140625
▁information 3.822265625
▁for 3.8515625
▁subsequent 4.3359375
▁un 7.80859375
comp 5.38671875
licated 0.084716796875
▁services 11.8125
. 0.6875
▁Thus 4.37890625
, 0.0266571044921875
▁research 4.4453125
ers 0.73828125
▁can 1.396484375
▁compare 4.10546875
▁the 0.99560546875
▁effects 2.298828125
▁of 0.0791015625
▁medic 4.4453125
ations 0.91748046875
▁on 1.7578125
▁patients 2.423828125
▁of 4.84375
▁diverse 4.125
▁age 2.75
▁groups 0.74951171875
, 0.9287109375
▁background 5.05078125
s 0.364501953125
, 0.06475830078125
▁physical 5.2421875
▁conditions 1.2138671875
, 0.081298828125
▁emot 4.921875
ional 0.13037109375
▁states 1.3583984375
, 0.10125732421875
▁and 0.47802734375
▁so 3.2421875
▁on 0.390869140625
. 0.07501220703125
<0x0A> 0.79296875
The 1.2001953125
▁question 5.72265625
na 1.482421875
ires 0.0003781318664550781
▁used 2.4296875
▁different 10.21875
▁variable 8.765625
▁measures 4.6328125
▁to 1.6689453125
▁collect 2.140625
▁information 2.025390625
. 1.8017578125
▁For 2.072265625
▁example 0.3779296875
, 0.0157623291015625
▁it 3.814453125
▁included 3.595703125
▁compreh 8.5390625
ensive 0.036468505859375
▁so 7.67578125
cio 0.199951171875
- 0.72216796875
dem 0.280029296875
ographic 0.043914794921875
▁data 1.111328125
: 5.79296875
▁gender 1.728515625
, 0.103515625
▁age 0.4365234375
, 0.09466552734375
▁country 4.578125
, 1.2216796875
▁type 4.4296875
▁of 0.06903076171875
▁residence 4.7265625
▁( 3.447265625
urban 2.09375
/ 3.224609375
r 0.06396484375
ural 0.0005884170532226562
), 0.306640625
▁years 6.296875
▁of 0.2017822265625
▁education 1.498046875
, 0.2001953125
▁and 1.6748046875
▁employ 3.68359375
ment 0.003696441650390625
▁status 0.515625
. 0.147216796875
▁Pat 4.96875
ients 0.098388671875
▁were 1.1455078125
▁also 1.2109375
▁asked 0.7802734375
▁about 0.94580078125
▁their 0.603515625
▁medical 2.828125
▁history 0.40478515625
▁over 8.8671875
▁the 0.204345703125
▁years 3.0703125
▁and 1.8857421875
▁the 1.935546875
▁current 4.29296875
▁presence 5.62890625
▁of 0.06695556640625
▁any 2.958984375
▁severe 4.828125
▁dise 2.798828125
ases 0.00011801719665527344
▁such 4.078125
▁as 0.010009765625
▁heart 2.529296875
▁failure 2.05078125
, 0.2308349609375
▁di 2.0078125
ab 0.0027923583984375
etes 0.005615234375
, 0.114990234375
▁ar 3.80859375
th 0.10906982421875
rit 0.033782958984375
is 0.011383056640625
, 0.064208984375
▁and 1.60546875
▁so 0.92236328125
▁on 0.03765869140625
. 0.05712890625
▁The 1.87109375
▁third 6.6484375
▁measure 4.0859375
▁of 2.1640625
▁the 0.982421875
▁question 2.9453125
naire 0.133544921875
▁was 1.1171875
▁indicated 9.28125
▁by 0.9365234375
▁information 5.6796875
▁on 1.6396484375
▁any 5.57421875
▁twelve 14.2734375
- 1.0322265625
month 0.60546875
▁and 6.0078125
▁lifetime 3.20703125
▁drug 4.2109375
▁and 4.16015625
▁alco 0.10552978515625
hol 0.00022399425506591797
▁consumption 2.43359375
. 0.426513671875
▁In 3.474609375
▁addition 0.83935546875
, 0.1407470703125
▁the 1.53125
▁record 7.9296875
▁included 1.5546875
▁a 2.68359375
▁pain 7.19921875
▁measurement 4.6328125
▁scale 0.95458984375
▁from 4.15234375
▁ 1.0166015625
0 0.450439453125
▁to 0.432861328125
▁ 0.046051025390625
1 0.3701171875
0 0.188720703125
▁to 4.57421875
▁evaluate 1.8642578125
▁dis 6.25
com 0.08447265625
fort 0.001861572265625
▁feelings 6.8125
▁during 3.4765625
▁the 0.83984375
▁last 1.798828125
▁month 1.494140625
. 0.351806640625
<0x0A> 1.18359375
The 1.1884765625
▁analysis 4.84375
▁of 0.5234375
▁any 7.5390625
▁human 7.74609375
▁reaction 4.31640625
▁has 4.81640625
▁a 2.619140625
▁high 4.44921875
▁potential 3.310546875
▁of 1.59375
▁subject 6.9140625
iveness 3.68359375
▁and 1.2607421875
▁bias 2.6796875
, 1.974609375
▁especially 2.234375
▁regarding 3.89453125
▁people 4.69921875
▁in 4.1875
▁severe 4.38671875
▁pain 0.50732421875
▁and 1.7978515625
▁un 5.87890625
stable 2.0859375
▁emot 0.82275390625
ional 0.359130859375
▁condition 2.0546875
. 0.09661865234375
▁Perhaps 8.6328125
▁some 5.41015625
▁patients 1.8515625
▁tend 4.94140625
▁to 0.0181121826171875
▁ex 2.10546875
agger 0.0015325546264648438
ate 0.00766754150390625
▁their 0.7646484375
▁de 6.30859375
press 1.38671875
ive 0.212158203125
▁state 3.095703125
▁or 1.9541015625
▁vice 7.11328125
▁vers 0.0310821533203125
a 0.0001398324966430664
, 1.0751953125
▁de 7.7890625
- 4.60546875
emph 0.87890625
as 0.006282806396484375
ize 0.11444091796875
▁serious 6.65625
▁difficulties 5.6796875
. 0.826171875
▁Because 6.23828125
▁the 2.328125
▁survey 5.71875
▁responses 6.83984375
▁were 1.54296875
▁thoroughly 7.78125
▁anonymous 5.05859375
, 0.431396484375
▁the 1.583984375
▁research 1.5771484375
ers 0.38525390625
▁were 1.5537109375
▁unable 2.162109375
▁to 0.0043792724609375
▁carefully 8.4921875
▁analyze 1.71875
▁each 4.1796875
▁patient 2.005859375
’ 26.921875
s 0.7626953125
▁reaction 3.380859375
▁and 2.3671875
▁compare 3.52734375
▁it 1.0888671875
▁to 1.3916015625
▁the 0.736328125
▁actual 4.76953125
▁states 7.03515625
▁of 0.458984375
▁condition 7.4765625
. 0.46435546875
▁More 6.8515625
▁accurate 3.927734375
▁answers 4.18359375
▁could 2.65625
▁be 0.7529296875
▁obtained 1.337890625
▁by 1.39453125
▁professional 7.76171875
▁psych 2.65234375
olog 0.5107421875
ists 0.0021839141845703125
▁via 7.56640625
▁personal 4.19921875
▁communication 4.67578125
▁and 1.96875
▁behavior 6.76171875
al 0.34130859375
▁analysis 2.625
. 0.2418212890625
▁However 2.48828125
, 0.0030460357666015625
▁this 2.158203125
▁method 2.998046875
▁of 2.494140625
▁research 2.46875
▁is 1.123046875
▁way 8.1015625
▁more 1.6142578125
▁resource 6.43359375
- 0.53466796875
int 0.6220703125
ensive 0.0086517333984375
▁and 0.61474609375
▁energy 8.53125
- 0.1524658203125
consum 0.3046875
ing 0.0036468505859375
. 0.626953125
<0x0A> 0.8212890625
The 1.4990234375
▁study 2.2421875
▁conducted 4.796875
▁a 2.81640625
▁correlation 6.13671875
▁type 7.03125
▁of 0.27978515625
▁research 2.26953125
▁with 3.025390625
▁variable 7.8359375
▁measures 1.787109375
. 1.40234375
▁It 2.087890625
▁evaluated 4.375
▁the 0.453125
▁inter 6.37890625
dep 2.73046875
end 0.0006999969482421875
ence 0.021392822265625
▁of 0.60400390625
▁various 3.74609375
▁factors 1.5966796875
▁that 2.775390625
▁affected 4.140625
▁the 0.55712890625
▁physical 6.38671875
▁and 1.2265625
▁emot 0.33935546875
ional 0.00098419189453125
▁condition 0.89306640625
▁of 0.1070556640625
▁patients 0.5693359375
▁experien 4.54296875
cing 0.00011026859283447266
▁chron 0.462646484375
ic 0.0009527206420898438
▁pain 0.034393310546875
. 0.310302734375
▁For 2.599609375
▁example 0.317138671875
, 0.0172271728515625
▁the 1.435546875
▁survey 4.5859375
▁showed 3.318359375
▁that 0.60302734375
▁the 1.658203125
▁ratio 7.57421875
▁of 0.132080078125
▁female 6.046875
▁patients 0.49560546875
▁was 2.20703125
▁remark 8.9375
ably 0.00051116943359375
▁higher 0.55078125
▁in 2.912109375
▁the 2.462890625
▁op 5.40234375
i 2.357421875
ates 0.04132080078125
▁group 0.69677734375
▁compared 2.876953125
▁to 0.1512451171875
▁the 0.54638671875
▁MM 1.2236328125
▁group 0.392578125
. 0.281005859375
▁In 2.6015625
▁turn 4.28515625
, 0.009063720703125
▁people 4.64453125
▁on 5.4375
▁op 1.185546875
i 0.286865234375
ates 0.0033931732177734375
▁were 1.560546875
▁more 1.2109375
▁likely 0.58740234375
▁to 0.05853271484375
▁report 2.6015625
▁major 6.24609375
▁de 0.86669921875
press 1.2080078125
ive 0.007144927978515625
▁dis 1.13671875
orders 0.70361328125
. 1.6650390625
<0x0A> 2.177734375
Part 5.796875
icip 0.308349609375
ants 0.0474853515625
▁were 1.2431640625
▁rec 1.818359375
ru 0.0007648468017578125
ited 1.8835067749023438e-05
▁for 0.84765625
▁six 0.9912109375
▁months 0.0210113525390625
▁at 0.472412109375
▁two 0.11572265625
▁major 0.43212890625
▁pain 0.058685302734375
▁relief 0.03778076171875
▁cent 0.10302734375
ers 0.0085601806640625
▁in 0.11688232421875
▁Israel 0.09783935546875
. 0.1932373046875
▁All 3.798828125
▁patients 1.5634765625
▁experienced 4.609375
▁chron 1.6884765625
ic 0.001270294189453125
▁pain 0.10076904296875
▁for 3.17578125
▁at 0.6171875
▁least 0.0007748603820800781
▁ 1.806640625
3 1.34765625
▁months 0.244873046875
. 0.83349609375
▁The 1.3935546875
▁study 1.796875
▁included 2.35546875
▁ 1.6279296875
8 2.853515625
9 2.634765625
0 3.33203125
▁participants 1.7255859375
, 1.4150390625
▁of 1.767578125
▁which 0.422607421875
▁ 0.1861572265625
4 1.4501953125
7 2.427734375
4 2.705078125
▁( 2.353515625
5 0.09735107421875
9 10.8671875
%) 0.76904296875
▁were 0.50927734375
▁treated 4.1875
▁sole 6.48828125
ly 0.0011138916015625
▁with 0.359375
▁op 0.2490234375
io 2.150390625
ids 0.19775390625
, 1.2802734375
▁ 0.6630859375
3 1.046875
2 1.7021484375
9 2.939453125
▁( 0.065673828125
4 1.298828125
1 1.0810546875
%) 0.09100341796875
▁were 1.53125
▁treated 0.34521484375
▁with 0.316650390625
▁MM 1.44140625
, 0.43798828125
▁and 0.10174560546875
▁ 0.197509765625
7 2.783203125
7 2.587890625
▁( 0.1876220703125
8 3.47265625
. 1.1923828125
6 2.61328125
%) 0.055023193359375
▁acquired 9.28125
▁both 2.15625
▁( 6.23046875
Fe 9.9921875
ing 4.7734375
old 0.01192474365234375
▁et 1.890625
▁al 0.04986572265625
., 0.335693359375
▁ 0.013519287109375
2 0.2054443359375
0 0.002147674560546875
1 0.51318359375
7 2.248046875
). 0.1278076171875
▁The 1.61328125
▁remaining 6.59375
▁ten 7.3515625
▁participants 1.775390625
▁who 5.7265625
▁did 1.2431640625
▁not 0.00836181640625
▁receive 1.7685546875
▁ph 3.076171875
arma 0.07867431640625
ce 0.0020503997802734375
ut 3.3974647521972656e-05
ical 0.00502777099609375
▁op 0.583984375
io 0.32861328125
ids 0.0328369140625
▁and 1.98828125
▁medical 2.4765625
▁mar 0.0623779296875
iju 0.004665374755859375
ana 0.0003402233123779297
▁were 1.208984375
▁with 6.55859375
dra 0.21240234375
wn 0.0001519918441772461
▁from 0.26953125
▁the 0.16455078125
▁analysis 3.765625
▁in 4.4296875
▁the 1.2763671875
▁research 4.03125
. 0.79443359375
▁Therefore 4.70703125
, 0.01558685302734375
▁it 2.99609375
▁is 1.076171875
▁not 2.787109375
▁possible 0.62890625
▁to 0.02099609375
▁compreh 6.50390625
ens 0.0406494140625
ively 0.005054473876953125
▁compare 1.7470703125
▁patients 5.00390625
▁taking 4.67578125
▁medic 3.8984375
ations 0.55078125
▁with 0.62451171875
▁those 1.9072265625
▁who 1.537109375
▁do 1.8212890625
▁not 0.01392364501953125
. 1.1357421875
<0x0A> 0.7138671875
Am 6.015625
ong 0.00933837890625
▁all 2.634765625
▁participants 1.4794921875
▁in 3.603515625
▁the 0.2149658203125
▁study 0.433837890625
, 0.097900390625
▁ 0.755859375
4 1.904296875
2 2.41015625
. 1.8447265625
2 2.287109375
% 0.09881591796875
▁suffered 4.484375
▁from 0.15625
▁de 2.0234375
pression 0.18701171875
, 1.05078125
▁and 1.94140625
▁ 0.1451416015625
3 1.5615234375
7 2.154296875
% 2.603515625
▁experienced 2.37109375
▁excess 8.046875
ive 0.22607421875
▁anx 0.77294921875
iety 0.0020771026611328125
. 0.38232421875
▁The 1.626953125
▁pl 10.859375
ur 1.037109375
ality 0.00017261505126953125
▁of 0.190185546875
▁de 3.52734375
press 1.408203125
ive 0.034912109375
▁dis 1.892578125
orders 0.051025390625
▁among 3.228515625
▁patients 1.111328125
▁in 3.3984375
▁the 0.434326171875
▁op 1.892578125
i 1.5791015625
ates 0.0121002197265625
, 7.28125
▁medical 4.1328125
▁mar 0.039276123046875
iju 0.00789642333984375
ana 0.0001647472381591797
, 0.3681640625
▁and 0.1005859375
▁mixed 5.890625
▁OP 7.8046875
MM 6.96484375
▁groups 0.8564453125
▁number 7.36328125
ed 0.01373291015625
▁ 0.129150390625
5 1.87890625
7 2.42578125
. 0.251708984375
1 2.375
%, 0.32177734375
▁ 0.007099151611328125
2 3.25
2 2.47265625
. 0.1180419921875
3 2.216796875
%, 0.13232421875
▁and 0.03302001953125
▁ 0.0036640167236328125
5 3.193359375
1 2.640625
. 0.1756591796875
4 2.158203125
%, 0.409912109375
▁respectively 0.01141357421875
. 0.318359375
▁The 1.578125
▁pl 4.28515625
ur 0.036346435546875
ality 5.7578086853027344e-05
▁of 0.05645751953125
▁anx 1.0126953125
iety 0.0132904052734375
▁contained 10.8515625
▁ 0.43994140625
4 1.580078125
8 2.310546875
. 0.06756591796875
4 2.30859375
% 0.57470703125
▁among 1.47265625
▁OP 6.62109375
▁patients 7.73046875
, 0.404296875
▁ 0.1729736328125
2 1.5556640625
1 2.40625
. 0.150390625
5 2.32421875
% 0.01061248779296875
▁among 0.37744140625
▁MM 0.50830078125
▁patients 0.2108154296875
, 0.0191650390625
▁and 0.0160064697265625
▁ 0.03759765625
3 1.2236328125
8 2.634765625
. 0.1630859375
7 2.27734375
% 0.0149688720703125
▁among 0.2164306640625
▁OP 4.13671875
MM 0.2425537109375
▁participants 3.703125
. 0.258056640625
▁Pat 6.1328125
ients 0.02142333984375
▁who 2.2890625
▁took 3.1640625
▁strong 8.015625
▁op 1.103515625
i 1.57421875
ates 0.00490570068359375
▁were 1.986328125
▁t 9.1015625
ended 1.2138671875
▁to 0.051025390625
▁place 10.3515625
▁their 3.6484375
▁pain 2.6484375
▁on 3.16796875
▁a 0.9169921875
▁scale 2.943359375
▁of 0.6142578125
▁ 0.3974609375
9 3.427734375
▁to 1.525390625
▁ 0.035858154296875
1 0.038330078125
0 0.08648681640625
▁( 2.380859375
Fe 1.9990234375
ing 0.016021728515625
old 0.0008478164672851562
▁et 0.061309814453125
▁al 0.002117156982421875
., 0.0180816650390625
▁ 0.002193450927734375
2 0.0009732246398925781
0 0.0004298686981201172
1 0.0026035308837890625
7 0.0220489501953125
). 0.053741455078125
▁They 5.0
▁were 1.48828125
▁also 1.537109375
▁an 8.0546875
gu 4.42578125
ished 0.036529541015625
▁em 9.0859375
otion 0.0121002197265625
ally 0.002655029296875
▁and 1.2744140625
▁react 7.109375
ed 0.05224609375
▁rad 9.5625
ically 0.0042572021484375
▁neg 5.1875
atively 0.0011510848999023438
▁to 0.33642578125
▁almost 5.93359375
▁all 1.0263671875
▁survey 9.0
▁questions 0.8720703125
. 0.31396484375
▁Pat 3.685546875
ients 0.006763458251953125
▁who 1.10546875
▁took 1.6845703125
▁only 6.33984375
▁MM 1.2998046875
▁or 3.4453125
▁mixed 3.845703125
▁medic 3.017578125
ations 0.39697265625
▁course 11.953125
▁had 2.53125
▁a 1.3134765625
▁significantly 2.931640625
▁more 3.517578125
▁stable 3.90625
▁emot 1.2421875
ional 0.016876220703125
▁state 0.95849609375
▁and 1.37890625
▁cop 5.4453125
ed 0.85546875
▁with 0.6376953125
▁pain 1.4501953125
▁more 1.5849609375
▁manage 5.91015625
able 2.37890625
. 0.58642578125
<0x0A> 0.8369140625
One 5.0546875
▁of 0.484375
▁the 0.018707275390625
▁major 2.494140625
▁limitations 2.970703125
▁is 3.705078125
▁the 0.54345703125
▁ins 4.50390625
u 0.025115966796875
fficient 0.20458984375
ly 4.76953125
▁high 3.107421875
▁response 3.48046875
▁rate 0.18994140625
, 2.79296875
▁ 5.13671875
5 2.111328125
7 1.90625
% 2.1953125
▁instead 7.25
▁of 0.0080413818359375
▁ 0.6533203125
7 1.568359375
0 1.3466796875
% 0.9951171875
▁( 1.650390625
Fe 0.366455078125
ing 0.0045623779296875
old 0.0005626678466796875
▁et 0.0177001953125
▁al 0.001369476318359375
., 0.007404327392578125
▁ 0.0015544891357421875
2 0.0005865097045898438
0 0.00847625732421875
1 0.0009765625
7 0.006565093994140625
). 0.042999267578125
▁It 2.779296875
▁can 3.35546875
▁be 0.412109375
▁fairly 8.4296875
▁explained 1.46875
▁by 0.18505859375
▁the 0.308349609375
▁weak 7.75
▁focus 7.421875
▁of 0.4814453125
▁respond 6.53125
ents 0.1221923828125
▁who 3.46875
▁have 4.0
▁overcome 7.8515625
▁severe 2.5703125
▁pain 0.6748046875
▁sens 8.3046875
ations 1.7333984375
▁and 1.2998046875
▁de 3.447265625
press 1.6884765625
ive 0.330322265625
▁episodes 4.23046875
. 0.4892578125
▁It 3.283203125
▁is 0.92529296875
▁not 2.818359375
▁clear 4.0390625
▁how 1.7666015625
▁to 3.564453125
▁use 5.38671875
▁these 3.115234375
▁statistics 3.625
, 2.92578125
▁as 1.443359375
▁they 1.80078125
▁still 5.0703125
▁may 4.74609375
▁be 1.642578125
▁relevant 4.5703125
▁for 1.3349609375
▁the 1.640625
▁overall 4.7265625
▁analysis 3.03515625
. 1.2939453125
